Table 6 ASR of specific haematological cancer categories in Sarawak 2008 to 2012 and other countries/continents 2008 to 2012
From: The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015)
Country/Continent | HL (C81) | NHL (C82-86, C96) | Multiple myeloma (C90) | |||
|---|---|---|---|---|---|---|
Male | Female | Male | Female | Male | Female | |
Sarawak – all ethnic | 0.9 | 0.7 | 5.3 | 4.0 | 0.8 | 0.7 |
Sarawak – Malay | 0.7 | 0.8 | 5.9 | 4.6 | 0.3 | 0.5 |
Sarawak – Chinese | 0.7 | 0.9 | 4.4 | 3.5 | 0.8 | 0.7 |
Sarawak – Iban | 1.0 | 0.4 | 5.6 | 3.8 | 1.1 | 0.9 |
Sarawak – Bidayuh | 1.3 | 1.1 | 6.8 | 6.2 | 0.6 | 1.5 |
Sarawak – Melanau | 0.6 | 0.0 | 4.1 | 3.6 | 1.1 | 0.3 |
Malaysia (Penang) – all ethnic | 0.9 | 0.5 | 7.4 | 5.5 | 0.8 | 0.7 |
Malaysia (Penang) – Malay | 1.1 | 0.6 | 6.6 | 5.8 | 0.8 | 0.7 |
Malaysia (Penang) – Chinese | 0.7 | 0.4 | 7.6 | 5.8 | 0.9 | 0.6 |
Singapore | NA | NA | NA | NA | NA | NA |
Thailand | 0.1 to 0.9 | 0.2 to 0.5 | 5.6 to 9.2 | 3.7 to 6.7 | 0.9 to 1.2 | 0.8 to 1.2 |
Indonesia | NA | NA | NA | NA | NA | NA |
China | 0.1 to 0.9 | 0.1 to 0.6 | 1.8 to 7.6 | 1.1 to 5.4 | 0.3 to 4.5 | 0.1 to 0.3 |
Korea (South) | 0.3 to 0.7 | 0.2 to 0.4 | 6.5 | 4.1 | 1.8 | 1.2 |
Japan | 0.6 to 1.2 | 0.4 to 0.7 | 7.9 to 10.0 | 5.8 to 6.8 | 1.6 to 2.1 | 1.2 to 1.6 |
Western Europe: UK | 2.9 | 2.2 | 12.4 | 9.0 | 4.6 | 3.0 |
Eastern Europe: Russian | 1.6 to 2.8 | 1.5 to 2.6 | 3.9 to 5.5 | 3.2 to 4.0 | 1.0 to 1.7 | 1.3 to 1.6 |
North America: USA | 2.7 | 2.2 | 14.1 | 9.7 | 4.7 | 3.2 |
South America: Brazil | 1.2 to 3.1 | 1.4 to 2.2 | 6.4 to 15.0 | 5.2 to 9.9 | 2.4 to 5.1 | 1.9 to 4.2 |
Africa | 0.4 to 1.8 | 0.0 to 2.3 | 1.6 to 16.1 | 1.1 to 11.8 | 0.5 to 3.7 | 0.2 to 4.0 |
Oceania: Australia | 2.7 | 2.1 | 15.3 | 10.3 | 4.9 | 3.2 |